跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 67,049 条关于
“Alpha-1 Antitrypsin deficiency”
全部
67,049
临床试验
41,506
药物
8,114
机构
1,402
资讯
16,027
去年
Intellia Therapeutics Initiates Phase 1/2 Trial of NTLA-3001 for AATD-Associated Lung Disease
去年
Beam Therapeutics Achieves Breakthrough in Base Editing for Alpha-1 Antitrypsin Deficiency
去年
FDA Approves Larger Vial Sizes of Takeda's GLASSIA for Alpha-1 Antitrypsin Deficiency
11个月前
Sanofi's Efdoralprin Alfa Achieves Primary Endpoints in Phase 2 Alpha-1 Antitrypsin Deficiency Study
去年
UT Southwestern Scientists Develop Targeted Gene Therapy for Alpha-1 Antitrypsin Deficiency Using Designer Lipid Nanoparticles
9个月前
Regeneron Partners with Tessera in $275M Gene Editing Deal for Alpha-1 Antitrypsin Deficiency Treatment
去年
Prime Medicine Advances Gene Editing Program for Alpha-1 Antitrypsin Deficiency with 72% Correction Rate
7个月前
YolTech's YOLT-202 Gene Editing Therapy Shows Promising Results in Alpha-1 Antitrypsin Deficiency Trial
去年
Wave Life Sciences' WVE-006 Demonstrates Durable AAT Protein Production in Alpha-1 Antitrypsin Deficiency Trial
去年
Beam Therapeutics Reports Breakthrough in Alpha-1 Antitrypsin Deficiency Treatment with BEAM-302 Base Editing Therapy
第 1 页，共 1603 页
上一页
下一页
